
Robert Stockton Jones Jr.
Examiner (ID: 3854)
| Most Active Art Unit | 1762 |
| Art Unit(s) | 1796, 1762 |
| Total Applications | 1302 |
| Issued Applications | 945 |
| Pending Applications | 17 |
| Abandoned Applications | 352 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6770444
[patent_doc_number] => 20030216384
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-20
[patent_title] => 'Composition and method for treating hypertension'
[patent_app_type] => new
[patent_app_number] => 10/255447
[patent_app_country] => US
[patent_app_date] => 2002-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7387
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20030216384.pdf
[firstpage_image] =>[orig_patent_app_number] => 10255447
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/255447 | Composition and method for treating hypertension | Sep 24, 2002 | Abandoned |
Array
(
[id] => 7270485
[patent_doc_number] => 20040059003
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-25
[patent_title] => 'NMDA receptor antagonist formulation with reduced neurotoxicity'
[patent_app_type] => new
[patent_app_number] => 10/256283
[patent_app_country] => US
[patent_app_date] => 2002-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13343
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20040059003.pdf
[firstpage_image] =>[orig_patent_app_number] => 10256283
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/256283 | NMDA receptor antagonist formulation with reduced neurotoxicity | Sep 24, 2002 | Issued |
Array
(
[id] => 6721387
[patent_doc_number] => 20030055077
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-20
[patent_title] => 'Method and compositions for the treatment of allergic conditions using pgd2 receptor antagonists'
[patent_app_type] => new
[patent_app_number] => 10/239717
[patent_app_country] => US
[patent_app_date] => 2002-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7868
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20030055077.pdf
[firstpage_image] =>[orig_patent_app_number] => 10239717
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/239717 | Method and compositions for the treatment of allergic conditions using pgd2 receptor antagonists | Sep 24, 2002 | Abandoned |
Array
(
[id] => 7265165
[patent_doc_number] => 20040242701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Amines as ant-alcoholism agents'
[patent_app_type] => new
[patent_app_number] => 10/489251
[patent_app_country] => US
[patent_app_date] => 2004-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3401
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0242/20040242701.pdf
[firstpage_image] =>[orig_patent_app_number] => 10489251
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/489251 | Amines as anti-alcoholism agents | Sep 18, 2002 | Issued |
Array
(
[id] => 6751040
[patent_doc_number] => 20030045561
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-06
[patent_title] => 'Method of treating isolated systolic hypertension'
[patent_app_type] => new
[patent_app_number] => 10/247035
[patent_app_country] => US
[patent_app_date] => 2002-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1819
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20030045561.pdf
[firstpage_image] =>[orig_patent_app_number] => 10247035
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/247035 | Method of treating isolated systolic hypertension | Sep 18, 2002 | Abandoned |
Array
(
[id] => 6814179
[patent_doc_number] => 20030073729
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-17
[patent_title] => 'Medicaments for diabetic complication and neuropathy, and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/244433
[patent_app_country] => US
[patent_app_date] => 2002-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4928
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20030073729.pdf
[firstpage_image] =>[orig_patent_app_number] => 10244433
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/244433 | Medicaments for diabetic complication and neuropathy, and uses thereof | Sep 16, 2002 | Abandoned |
Array
(
[id] => 6688930
[patent_doc_number] => 20030032655
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-13
[patent_title] => 'Heme oxygenase-1 inducers or induction enhancers'
[patent_app_type] => new
[patent_app_number] => 10/221798
[patent_app_country] => US
[patent_app_date] => 2002-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2712
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20030032655.pdf
[firstpage_image] =>[orig_patent_app_number] => 10221798
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/221798 | Heme oxygenase-1 inducers or induction enhancers | Sep 16, 2002 | Abandoned |
Array
(
[id] => 720323
[patent_doc_number] => 07049334
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-05-23
[patent_title] => 'Enhancement of learning and memory and treatment of amnesia'
[patent_app_type] => utility
[patent_app_number] => 10/242826
[patent_app_country] => US
[patent_app_date] => 2002-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6216
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/049/07049334.pdf
[firstpage_image] =>[orig_patent_app_number] => 10242826
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/242826 | Enhancement of learning and memory and treatment of amnesia | Sep 12, 2002 | Issued |
Array
(
[id] => 6818277
[patent_doc_number] => 20030069235
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-10
[patent_title] => 'Treatment for ocular infections'
[patent_app_type] => new
[patent_app_number] => 10/238449
[patent_app_country] => US
[patent_app_date] => 2002-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3278
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20030069235.pdf
[firstpage_image] =>[orig_patent_app_number] => 10238449
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/238449 | Treatment for ocular infections | Sep 9, 2002 | Abandoned |
Array
(
[id] => 6740868
[patent_doc_number] => 20030158237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-21
[patent_title] => 'Combination of antioxidant substances for the treatment of alzheimer\'s disease'
[patent_app_type] => new
[patent_app_number] => 10/235613
[patent_app_country] => US
[patent_app_date] => 2002-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10275
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20030158237.pdf
[firstpage_image] =>[orig_patent_app_number] => 10235613
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/235613 | Combination of antioxidant substances for the treatment of alzheimer's disease | Sep 3, 2002 | Abandoned |
Array
(
[id] => 6674820
[patent_doc_number] => 20030060423
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-27
[patent_title] => 'Co-therapy for the treatment of dementia and associated behavioral manifestations comprising anticonvulsant derivatives and acetylcholinesterase inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/229878
[patent_app_country] => US
[patent_app_date] => 2002-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6281
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0060/20030060423.pdf
[firstpage_image] =>[orig_patent_app_number] => 10229878
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/229878 | Co-therapy for the treatment of dementia and associated behavioral manifestations comprising anticonvulsant derivatives and acetylcholinesterase inhibitors | Aug 27, 2002 | Abandoned |
Array
(
[id] => 6779241
[patent_doc_number] => 20030050323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-13
[patent_title] => 'Farnesyl protein transferase inhibitor combinations with anti-tumor podophyllotoxin derivatives'
[patent_app_type] => new
[patent_app_number] => 10/220216
[patent_app_country] => US
[patent_app_date] => 2002-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10096
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0050/20030050323.pdf
[firstpage_image] =>[orig_patent_app_number] => 10220216
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/220216 | Farnesyl protein transferase inhibitor combinations with anti-tumor podophyllotoxin derivatives | Aug 27, 2002 | Abandoned |
Array
(
[id] => 582752
[patent_doc_number] => 07449451
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-11-11
[patent_title] => 'Use of multiple antioxidant micronutrients as systemic biological radioprotective agents against potential ionizing radiation risks'
[patent_app_type] => utility
[patent_app_number] => 10/229274
[patent_app_country] => US
[patent_app_date] => 2002-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6536
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/449/07449451.pdf
[firstpage_image] =>[orig_patent_app_number] => 10229274
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/229274 | Use of multiple antioxidant micronutrients as systemic biological radioprotective agents against potential ionizing radiation risks | Aug 27, 2002 | Issued |
Array
(
[id] => 6745735
[patent_doc_number] => 20030022918
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-30
[patent_title] => 'Farnesyl protein transferase inhibitor combinations with an her2 antibody'
[patent_app_type] => new
[patent_app_number] => 10/220217
[patent_app_country] => US
[patent_app_date] => 2002-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9927
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20030022918.pdf
[firstpage_image] =>[orig_patent_app_number] => 10220217
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/220217 | Farnesyl protein transferase inhibitor combinations with an her2 antibody | Aug 27, 2002 | Abandoned |
Array
(
[id] => 6658307
[patent_doc_number] => 20030078281
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-24
[patent_title] => 'Farnesyl protein transferase inhibitor combinations with anti-tumor alkylating agents'
[patent_app_type] => new
[patent_app_number] => 10/220220
[patent_app_country] => US
[patent_app_date] => 2002-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10462
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0078/20030078281.pdf
[firstpage_image] =>[orig_patent_app_number] => 10220220
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/220220 | Farnesyl protein transferase inhibitor combinations with anti-tumor alkylating agents | Aug 27, 2002 | Abandoned |
Array
(
[id] => 6761964
[patent_doc_number] => 20030125326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-03
[patent_title] => 'Farnesyl protein transferase inhibitor combinations'
[patent_app_type] => new
[patent_app_number] => 10/220218
[patent_app_country] => US
[patent_app_date] => 2002-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10475
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0125/20030125326.pdf
[firstpage_image] =>[orig_patent_app_number] => 10220218
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/220218 | Farnesyl protein transferase inhibitor combinations | Aug 27, 2002 | Abandoned |
Array
(
[id] => 6674877
[patent_doc_number] => 20030060480
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-27
[patent_title] => 'Farnesyl protein transferase inhibitor combinations with vinca alkaloids'
[patent_app_type] => new
[patent_app_number] => 10/220398
[patent_app_country] => US
[patent_app_date] => 2002-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10114
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0060/20030060480.pdf
[firstpage_image] =>[orig_patent_app_number] => 10220398
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/220398 | Farnesyl protein transferase inhibitor combinations with vinca alkaloids | Aug 27, 2002 | Abandoned |
Array
(
[id] => 6745631
[patent_doc_number] => 20030022814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-30
[patent_title] => 'Method for treating or preventing depression'
[patent_app_type] => new
[patent_app_number] => 10/204876
[patent_app_country] => US
[patent_app_date] => 2002-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11183
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20030022814.pdf
[firstpage_image] =>[orig_patent_app_number] => 10204876
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/204876 | Method for treating or preventing depression | Aug 22, 2002 | Abandoned |
Array
(
[id] => 6674908
[patent_doc_number] => 20030060511
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-27
[patent_title] => 'Method for treatment of ocular hypertension and glaucoma'
[patent_app_type] => new
[patent_app_number] => 10/224923
[patent_app_country] => US
[patent_app_date] => 2002-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4859
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0060/20030060511.pdf
[firstpage_image] =>[orig_patent_app_number] => 10224923
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/224923 | Method for treatment of ocular hypertension and glaucoma | Aug 21, 2002 | Abandoned |
Array
(
[id] => 6652950
[patent_doc_number] => 20030008809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-09
[patent_title] => 'Use of 5-HT (3) receptor antagonists for treating musculoeskeletal diseases'
[patent_app_type] => new
[patent_app_number] => 10/224938
[patent_app_country] => US
[patent_app_date] => 2002-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5070
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 158
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20030008809.pdf
[firstpage_image] =>[orig_patent_app_number] => 10224938
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/224938 | Use of 5-HT3 receptor antagonists for treating musculoskeletal diseases | Aug 20, 2002 | Issued |